Condition
Herpes Simplex Type II
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01315054Not ApplicableCompleted
A Methadone Maintenance Treatment Outcome Study in Three Provinces in China
NCT01448616Phase 4CompletedPrimary
Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding
NCT03090802Not ApplicableCompleted
MAMAS: Mentoring Adolescent Mothers at School
NCT00860977Phase 3Completed
Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?
Showing all 4 trials